Department of Hematopathology, MS-072, The University Texas MD Anderson Cancer Center, Houston, TX 77401, USA.
Department of Pathology, UT Southwestern Medical Center, BioCenter EB3.234, 2330 Inwood Road, EB3.234, Dallas, TX 75390-9317, USA.
Semin Diagn Pathol. 2020 Nov;37(6):296-302. doi: 10.1053/j.semdp.2020.06.002. Epub 2020 Jun 12.
Myeloid diseases detected as primary or secondary lesions in the lung and pleura are rare. Clinical presentations and radiographic results may vary significantly depending on the nature of the diseases. The most common diseases associated with lung and pleura involvement are myeloid sarcoma/acute myeloid leukemia (AML) and extramedullary hematopoiesis (EMH). AML typically represents localized involvement by systemic acute leukemia, while EMH is frequently secondary to underlying benign hematolymphoid disorders or myeloproliferative neoplasms. This review provides an overview of the pathogenesis, clinical presentations, radiologic/imaging studies, pathologic and genetic findings, and treatment/outcomes associated with myeloid diseases in the lung and pleura.
肺部和胸膜原发性或继发性髓系疾病较为罕见。临床表现和影像学结果可能因疾病性质而有很大差异。最常见的与肺和胸膜受累相关的疾病是髓肉瘤/急性髓系白血病(AML)和髓外造血(EMH)。AML 通常代表全身性急性白血病的局部受累,而 EMH 则常继发于潜在的良性血液淋巴组织疾病或骨髓增殖性肿瘤。本文综述了肺部和胸膜髓系疾病的发病机制、临床表现、影像学研究、病理学和遗传学发现以及治疗结果。